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The STRIPAK complex components FAM40A
and FAM40B regulate endothelial cell
contractility via ROCKs
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Abstract
Background: Endothelial cells provide a barrier between blood and tissues, which is regulated to allow molecules
and cells in out of tissues. Patients with cerebral cavernous malformations (CCM) have dilated leaky blood vessels,
especially in the central nervous system. A subset of these patients has loss-of-function mutations in CCM3. CCM3
is part of the STRIPAK protein complex that includes the little-characterized proteins FAM40A and FAM40B.
Results: We show here that FAM40A and FAM40B can interact with CCM3. Knockdown of CCM3, FAM40A or FAM40B
in endothelial cells by RNAi causes an increase in stress fibers and a reduction in loop formation in an in vitro angiogenesis
assay, which can be reverted by inhibiting the Rho-regulated ROCK kinases. FAM40B depletion also increases endothelial
permeability.
Conclusions: These results demonstrate the importance of the FAM40 proteins for endothelial cell physiology, and suggest
that they act as part of the CCM3-containing STRIPAK complex.
Keywords: Cerebral cavernous malformations, Endothelial cells, Actin cytoskeleton, Adherens junctions, Rho/ROCK, STRIPAK
complex
Background
Cerebral cavernous malformation is a disease that affects
endothelial barrier integrity, particularly in the brain,
leading to conglomerations of distended capillaries [1].
Three different genes are mutated in patients with
CCM: CCM1/KRIT, CCM2/MGC4607 and CCM3/
PDCD10. The three CCM proteins all affect endothelial
cell function and have been reported to associate with
each other, at least when overexpressed [2], as well as
have similar effects on cellular responses, such as au-
tophagy [3]. However, the three proteins have no hom-
ology to each other and are found in different signalling
complexes [2]. In particular, CCM3 has been identified
as a component of the STRIPAK (striatin-interacting
phosphatase and kinase) complex, which was identified
through an interaction map around the protein phos-
phatase 2A (PP2A) catalytic subunit by an affinity
purification/mass spectrometry approach [4]. This STRI-
PAK complex includes striatin proteins, which are PP2A
regulatory subunit proteins and act as protein scaffolds
[5], Mob3, the GCKIII (germinal centre kinase III) ki-
nases (STK24, STK25 and MST4), another germinal
centre kinase MINK1 (misshapen like kinase 1) [6],
CCM3, and the FAM40 (FAMily with sequence similar-
ity 40) proteins FAM40A/STRIP1 and FAM40B/STRIP2.
CCM3 has been shown to be important for maintaining
endothelial junction integrity by preventing stress fiber in-
duction and associated contractility [7]. Mutations in
CCM3 lead to vascular malformations in the brain [8]. The
GCKIII kinases interact with CCM3 [9], and this inter-
action is central for CCM3 signalling with GCKIII kinases
being downstream effectors of CCM3 function [7]. Wild
type CCM3 can bind STK24, STK25 and MST4 while mu-
tant CCM3 protein (with a mutation linked to CCM) fails
to do so. Loss of STK25 and CCM3 function leads to vas-
cular development defects in zebrafish and confers a barrier
defect in cultured endothelial cells. STK24 and STK25 act
downstream of CCM3 to downregulate RhoA activity, pre-
venting loss of barrier function. However, it is not clear if
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CCM3 signals via RhoA as a second study failed to detect
increased RhoA activity upon CCM3 depletion by RNAi
[10]. Indeed, vascular anomalies observed upon CCM3
knockdown in zebrafish are distinct from those following
either CCM1 or CCM2 knockdown [11]. CCM3 could also
contribute to CCM through its role in regulating Golgi po-
sitioning and organisation via the GCKIII kinases, thereby
regulating endothelial junction formation [12].
Very little is known about the structure or function of
the STRIPAK complex-associated FAM40 proteins,
which are found in many eukaryotes including fungi.
FAM40A and FAM40B have 61% amino acid identity
and have two recognised domains, the N-terminal
N1221-like domain and the C-terminal DUF3402 (do-
main of unknown function 3402). Both these domains
are functionally uncharacterised and do not resemble
any other known protein domains.
The Drosophila FAM40 orthologue was one of many
genes identified in a genome-wide RNAi screen for genes
affecting cell shape in Drosophila S2 cells [13]. Data from
this initial RNAi screen were used to carry out a second
RNAi screen in PC3 prostate cancer cells to identify novel
regulators of cytoskeletal organisation, cell morphology
and migration [14]. Knockdown of FAM40A and FAM40B
in PC3 cells resulted in distinct morphological pheno-
types: FAM40A-depleted cells had a smaller cell area and
high levels of cortical F-actin compared to control cells,
whereas FAM40B-depleted cells had a larger spread area
and long thin protrusions [14]. Similarly, in A431 cells
FAM40A depletion increased actomyosin contractility
whereas FAM40B depletion increased cell spreading [15].
Here, we investigate the functions of FAM40A and
FAM40B in human endothelial cells, in comparison to
CCM3. We find that FAM40A and FAM40B can associate
with CCM3, and that all three genes have similar effects
in regulating stress fibers and angiogenic loop formation
via Rho/ROCK-mediated actomyosin contractility.
Results
CCM3 regulates stress fibers and affects endothelial loop
formation
The STRIPAK complex contains multiple proteins, includ-
ing CCM3, FAM40A and FAM40B [4] (Fig. 1a). CCM3 has
been reported to bind to GCKIII kinases and striatin [8],
but not to FAM40 proteins. We found that FAM40A and
FAM40B co-immunoprecipitated with CCM3 when they
were co-expressed in COS7 cells (Fig. 1b).
The CCM proteins have been shown to be important
for maintaining endothelial homeostasis by regulating cell
contractility. Depletion of CCM3 was reported to lead to
an induction of stress fibers in endothelial cells [7]. We
used two independent siRNAs targeting CCM3, which
consistently depleted CCM3 mRNA by at least 85%
(Fig. 2a). Human umbilical vein endothelial cells
(HUVECs) depleted of CCM3 exhibited increased stress
fibers (Fig. 2b). VE-cadherin localization at cell-cell junc-
tions was discontinuous along junctions at the ends of
cells where stress fibers from neighbouring cells met at
junctions (Fig. 2b; arrows), similar to our previous obser-
vations in TNFα-stimulated HUVECs [16]. We tested the
effect of CCM3 depletion in an in vitro loop formation
angiogenesis assay on Matrigel [17]. CCM3-depleted
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Fig. 1 FAM40A and FAM40B interact with CCM3. a Schematic showing key components of the human STRIPAK complex. b COS7 cells were co-
transfected with pDESTHA (empty vector) or pHA-FAM40A or pHA-FAM40B, and pmyc-CCM3. After 48 h, cells were lysed and whole cell lysates
incubated with anti-HA epitope agarose beads. Proteins interacting with the HA-FAM40 proteins were visualized by immunoblotting with an antibody
to the myc epitope. Lanes are taken from the same immunoblot. Immunoblots are representative of results from 3 independent experiments
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HUVECs had strong defects in endothelial loop formation
(Fig. 2c).
FAM40A and FAM40B regulate stress fibers in endothelial
cells
Given the strong phenotype of CCM3 depletion in endo-
thelial cells, we investigated whether the CCM3-
interacting proteins FAM40A or FAM40B induced simi-
lar phenotypes. Two independent siRNAs targeting
FAM40A reduced FAM40A mRNA levels by at least
50% in HUVECs (Fig. 3a). No antibody specific to
FAM40A is available, but an antibody to FAM40B
showed that two siRNAs targeting FAM40B reduced
protein expression levels (Fig. 3b). Depletion of FAM40A
a
b
c
Fig. 2 CCM3 regulates stress fibers and angiogenic loop formation in endothelial cells. HUVECs were transfected with siRNAs targeting CCM3 or
with a control siRNA. a After 72 h, the amount of CCM3 mRNA was determined by qPCR. Data are normalised to GAPDH mRNA levels and are
the mean of 3 independent experiments ± SEM. b Left panels, HUVECs were seeded onto fibronectin-coated glass coverslips to form confluent
monolayers. 72 h after transfection, cells were fixed and stained for F-actin and VE-cadherin. Images are compressed stacks of 10–15 confocal z-
sections. Arrows indicate discontinuous junctions (VE-cadherin); Scale bar, 40 μm. Intensity profiles are indicated for representative cells with the
region scanned indicated as a red line on each image. Right panel, stress fibers were quantified as described in Materials and Methods; data
show mean ± SEM; n = 3 independent experiments. At least 150 cells were scored per condition in each experiment. c Left panels, 48 h after
transfection, HUVECs were seeded onto a layer of Matrigel. Loops were allowed to form for 24 h, and then cells were fixed and stained for F-actin
with phalloidin-Alexa546. Scale bar, 100 μm. Right, loop formation was quantified by scoring the number of loops per field using fluorescence
images. 6 fields were scored per condition in each experiment. Results are shown as % of siControl. Data are mean ± SEM, n = 3 independent
experiments; **p < 0.01, ***p < 0.001 compared to siControl determined by Student’s t-test
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or FAM40B in HUVECs induced an increase in stress fi-
bers (Fig. 3c).
Since both FAM40 depletion and CCM3 depletion in-
duced an increase in stress fibers, we wondered whether
CCM3 overexpression could reduce the response to FAM40
depletion. However, CCM3 overexpression did not rescue
the FAM40 depletion-induced stress fiber response (Fig. 3d),
indicating that FAM40 proteins are not directly upstream of
CCM3. Instead, they probably all act together in the STRI-
PAK complex to regulate stress fiber assembly. This is
consistent with our observations with FAM40A/B overex-
pression (Fig. 3e). Neither induced a decrease in stress fibers,
consistent with a model in which multiple components of
the complex act together to regulate stress fiber levels. Both
FAM40A and FAM40B showed a diffuse cytoplasmic
localization in HUVECs, similar to CCM3 (Fig. 3e).
Rho/ROCK signalling is required for FAM40-regulated
stress fibers
Given that stress fiber formation is generally regulated by
Rho family GTPases, particularly the Rho subfamily mem-
bers RhoA, RhoB and RhoC [18], we tested whether these
Rho subfamily proteins were required for the increase in
stress fibers in response to FAM40A or FAM40B depletion.
HUVECs were incubated with the Clostridium botulinum
exoenzyme C3 transferase, which ADP-ribosylates RhoA,
RhoB and RhoC and thereby inhibits their activity [19]. C3
transferase prevented the increase in stress fibers induced by
FAM40A or FAM40B depletion (Fig. 4a). It also reduced the
level of non-stress fiber actin filaments (as observed in
siControl-transfected cells).
Stress fiber formation downstream of Rho subfamily pro-
teins is dependent on their downstream targets ROCK1 and
ROCK2 [20]. A small molecule inhibitor of ROCK1/2 kinase
activity, H1152 [21], also prevented the increase in stress fi-
bers induced by FAM40A or FAM40B depletion (Fig. 4b).
These results indicate that FAM40A and FAM40B normally
suppress Rho/ROCK-induced stress fiber assembly. Although
H1152 is highly selective for ROCKs, it can inhibit other
kinases at higher concentrations in vitro [28], and hence it is
possible that some of its effects are due to other kinases.
We did not observe an increase in total RhoA activity in
FAM40-depleted cells (Fig. 5a), or levels of phosphorylated
MLC2 (pMLC2) (Fig. 5b), which is often considered a
marker for ROCK activity [20]. As a control, thrombin
stimulation increased pMLC levels in HUVECs (Additional
file 1: Figure S1), as previously reported [22]. Notably,
pMLC2 localized along stress fibers in FAM40-depleted
HUVECs (Fig. 5c), indicating that they are contractile.
FAM40A and FAM40B depletion affects endothelial
junctions and permeability
We have previously shown that stress fibers in endothe-
lial cells are connected to cell-cell junctions and affect
junctional integrity [16]. We therefore investigated
whether FAM40A or FAM40B altered the distribution of
adherens junctional or tight junctional proteins. Neither
VE-cadherin (Fig. 6a) nor ZO-1, a component of tight
junctions (Fig. 6b) disappeared from junctions following
FAM40A or FAM40B depletion. However, in FAM40-
depleted cells, VE-cadherin localization at cell-cell junc-
tions was discontinuous along junctions at the ends of
cells where stress fibers from neighbouring cells met at
junctions (Fig. 6c), similar to our observations with
CCM3 depletion (Fig. 2b). Moreover, in FAM40B-
depleted cells, endothelial permeability was increased
(Fig. 6d), consistent with disruption in cell-cell junctions.
FAM40A depletion did not affect endothelial permeabil-
ity, suggesting that FAM40A and FAM40B could medi-
ate different as well as common functions in endothelial
cells.
FAM40A and FAM40B affect endothelial loop formation
Our results with CCM3 indicate that increased stress fi-
bers correlate with reduced endothelial loop formation
(Fig. 2). We therefore tested the effects of FAM40A and
FAM40B in this assay. Knockdown of both FAM40A
and FAM40B results in strong defects in the loop
(See figure on previous page.)
Fig. 3 FAM40A and FAM40B regulate stress fibers in endothelial cells. HUVECs were transfected with siRNAs targeting FAM40A, FAM40B or with a
control siRNA, and analysed 72 after transfection. a The amount of FAM40A mRNA was determined by quantitative PCR. Data are normalised to
GAPDH mRNA levels and are the mean ± SEM; n = 3. b Representative immunoblot of HUVEC lysates. Whole cell lysates were immunoblotted for
FAM40B and GAPDH as a loading control; arrow indicates FAM40B protein. Lanes are from the same immunoblot. Quantification of FAM40B band
intensities (to band) is shown above the blot, relative to siControl, and was carried out using ImageJ. c Cells were seeded onto fibronectin-coated
glass coverslips to form confluent monolayers. Cells were fixed and stained for F-actin. Images are compressed stacks of 10–15 z-sections. Scale
bar, 40 μm. Intensity profiles are indicated for representative cells with the region scanned indicated as a red line on each image. Graph
(right panel) shows quantification of stress fibers from at least 150 cells per condition from 3 independent experiments ± SEM. d HUVECs
were transfected with pHA-FAM40A, pHA-FAM40B or pmyc-CCM3, seeded onto fibronectin-coated glass coverslips and fixed after 24 h.
Cells were stained for F-actin and the HA or myc epitope. Images are compressed stacks of 15–20 z-sections (FAM40A/B) or single
images (CCM3) and are representative of 2 independent experiments. Scale bar, 20 μm. e HUVECs were transfected with control siRNA or
siRNAs targeting FAM40A or FAM40B, followed after 48 h by transfection with pmyc-CCM3. After a further 24 h, stress fibers were
quantified from at least 100 cells per condition from 2 independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001, n.s. not significant;
Student’s t-test, compared to siControl
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formation angiogenesis assay (Fig. 7a). Indeed, very few
loops were observed. Movies showed that the
FAM40-depleted endothelial cells transiently extended
protrusions but then collapsed into cell groups (Fig. 7b,
Additional files 2, 3, 4, 5, 6, and 7). Analysis of F-actin
distribution indicated that control cells formed chains of
single cells along the loops, whereas FAM40A or
FAM40B-depleted cells were predominantly in clumps
(Fig. 7c). Cells at the edge of the clumps had multiple
thin protrusions that are likely to be retraction fibers
which form as cells pull back from the matrix.
Given that inhibition of ROCK activity reduced stress
fiber levels in FAM40-depleted cells, we tested whether
ROCK also affected loop formation. Treatment with
the ROCK inhibitor Y-27632 rescued FAM40 depletion-
induced inhibition of loop formation (Fig. 7d, Additional
file 2). Taken together, these results indicate that ROCK-
mediated contractility drives the inhibition of loop forma-
tion in FAM40-depleted cells.
Discussion
CCM3 associates with the STRIPAK complex, which in-
cludes kinases and phosphatases and scaffolding proteins
[5]. CCM3 is well known to affect endothelial cell func-
tion in vitro and in vivo [2, 8]. FAM40A and FAM40B
are little-characterized members of the STRIPAK com-
plex, and their function in endothelial cells has not pre-
viously been addressed. Here, we show that CCM3
co-immunoprecipitates with FAM40A and FAM40B
when exogenously expressed in COS7 cells, indicating a
close association between the proteins. We demonstrate
that FAM40A and FAM40B depletion, like CCM3 deple-
tion, increases stress fibers and junctional disruption in
endothelial cells, and impairs angiogenesis in a loop for-
mation assay.
In endothelial cells, we found that depletion of either
FAM40A or FAM40B increased stress fibers in endothelial
monolayers, and cell contractility in loop angiogenesis assays.
In contrast, in PC3 cells, MDA-MB-231 breast cancer cells
and A431 cells, FAM40A and FAM40B depletion leads to
distinct phenotypes. For example, FAM40A depletion re-
sulted in reduced cell spreading, increased membrane bleb-
bing and higher levels of staining for phosphorylated MLC2
and phosphorylated ezrin/radixin/moesin proteins (pERM),
whereas FAM40B depletion increased cell spreading [14, 15].
While depletion of FAM40A and STRN3 gave similar phe-
notypes, depletion of other STRIPAK complex components,
the GCKIII kinases MST3 and MST4, led to a phenotype
that resembled FAM40B depletion [15]. This suggests that
different components of STRIPAK complexes have opposing
functions, and thus it is possible that distinct subcomplexes
exist dynamically in cells to regulate cell shape and the
cytoskeleton.
Whether FAM40A and FAM40B have different func-
tions or act in distinct complexes in endothelial cells is
not known. While their depletion had similar phenotypes
in nearly all the assays we used, only FAM40B affected
endothelial permeability, suggesting it might have a
unique function at endothelial junctions. Alternatively, it
could be that FAM40B is expressed at higher levels than
FAM40A in HUVECs and thus has a stronger effect on
permeability. It would be interesting to compare the ef-
fects of FAM40A and FAM40B depletion in other types of
endothelial cells, such as brain endothelial cells which
have better-developed tight junctions than HUVECs [1].
It is still unclear how CCM3 and other members of
the STRIPAK complex regulate actomyosin contractility
and cell shape. Although it has been reported that deple-
tion of CCM1 and CCM2 increases RhoA activity in hu-
man endothelial cells [23], we and others have not
observed any change in RhoA activity following CCM3,
FAM40A or FAM40B depletion [15], even though Rho
and ROCK function is required for the stress fiber for-
mation we observe in FAM40A/B-depleted endothelial
cells, and phospho-MLC2 staining is present on the
stress fibers. Instead, it has been suggested that CCM3
regulates the localisation of the STRIPAK complex
GCKIII kinases MST3 and MST4 under some condi-
tions [15], although it is not known whether FAM40A or
FAM40B have a similar function.
Given their effects on cell morphology and the actin
cytoskeleton, FAM40 proteins would be expected to in-
fluence cell migration. Indeed, the single FAM40 gene in
Drosophila is required for optimal border cell migration
in the Drosophila egg chamber [15]. Similarly, both
FAM40A and FAM40B depletion slightly reduces PC3
cell migration in 2D [14]. However, in MDA-MB-231
cells, FAM40B depletion increases migration in 2D, al-
though it reduces migration through small pores [15]. In
endothelial cells, we did not observe any effects of
(See figure on previous page.)
Fig. 4 Rho/ROCK signaling is required for stress fiber induction by FAM40 depletion. HUVECs were transfected with siRNAs targeting FAM40A,
FAM40B or a control siRNA and seeded onto fibronectin-coated glass coverslips to form confluent monolayers. 72 h after transfection cells were
treated with (a) 4 μg/ml C3 transferase for 2 h, or (b) 5 μM H1152 for 10 min after which they were fixed and stained for F-actin. Images are
compressed stacks of 10–15 z-sections. Scale bars, 40 μm. Graphs show stress fiber content quantified from at least 150 cells per condition from 3
independent experiments. Error bars depict SEM values. *** (black) p < 0.001; Student’s t-test, compared to siControl; *** (grey) p < 0.001; Student’s
t-test, comparison between siRNA+/− C3 transferase or H1152. (c) Intensity profiles are indicated for representative cells with the region scanned
indicated as a red line in each image in panels 4A and 4B
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Fig. 5 Effects of FAM40A or FAM40B on RhoA activity and MLC2 phosphorylation. a HUVECs were transfected with siRNAs targeting FAM40A or FAM40B.
After 72 h, cells were lysed and whole cell lysates used in a GST-RBD pulldown assay to determine levels of active GTP-loaded RhoA. A representative
immunoblot for total and GTP-loaded RhoA is shown (n= 3). b Immunoblot of phospho-MLC2 (pMLC2) and MLC2 in FAM40A and FAM40B-depleted
HUVECs. Quantification of pMLC2 levels was performed by individually normalising pMLC2 and MLC2 levels to GAPDH levels. The ratio of the normalised
pMLC2 level to the normalised MLC2 level was used as a measure of MLC2 phosphorylation. Data are means of 3 independent experiments ± SEM. n.s.
not significant; Student’s t-test compared to siControl. c HUVECs were transfected with siRNAs targeting FAM40A or FAM40B and seeded onto fibronectin-
coated glass coverslips to form confluent monolayers. 72 h after transfection cells were fixed and stained for F-actin and pMLC2. Images are compressed
stacks of 10–15 z-sections. Asterisks indicate examples of regions where pMLC2 co-localizes with stress fibers. Images shown are compressed stacks of 10–
15 z-sections and are representative of 2 independent experiments. Scale bar, 20 μm. Dual colour intensity profiles for F-actin and pMLC2 are indicated for
representative cells with the region scanned indicated as a red line on each image
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FAM40A or FAM40B on migration in a modified scratch
wound assay (unpublished data). These differences in
the effects of FAM40A and FAM40B on 2D migration
may reflect different cell types or conditions, and the
fact that FAM40 proteins do not appear to influence
Rho GTPase activity directly.
In addition to the well-characterized roles of CCM pro-
teins in endothelial cells, there is increasing evidence that
they contribute to the functions of other cell types, includ-
ing neurons and cancer cells [5]. For example, CCM3 fa-
cilitates interactions between neuroglia and endothelial
cells [24], while FAM40B has been shown to be important
for maintaining cell-cell contacts in HeLa cells [14].
FAM40B and the STRIPAK complex components CCM3
and the GCKIII kinases MST3 and MST4 are all required
for optimal survival of MDA-MB-231 breast cancer cells
in the lungs in vivo [15], although whether this reflects
their roles in cell migration or attachment to endothelial
cells is not known. The Far complex in budding yeast is
related to the human STRIPAK complex, and has been
proposed to facilitate the fusion of mating cells [25]. These
results together with our data in endothelial cells suggest
that a general role of the FAM40 proteins/STRIPAK com-
plex could be in mediating cell-cell contact formation
and/or maintenance.
FAM40A and FAM40B do not have any known cata-
lytic function, and are more likely to be scaffolding pro-
teins that facilitate protein-protein interactions, although
the only known direct interacting partners are striatins
[4]. Striatins themselves are also considered as protein
scaffolds, and indeed act in several different protein
complexes to facilitate signaling [26]. Interestingly, de-
pletion of the striatin STRN3 in human A431 carcinoma
cells led to a similar phenotype to FAM40A depletion,
indicating that they act on the same pathway.
Conclusions
Overall, our observations that CCM3, FAM40A and
FAM40B depletion all induce a similar phenotype in
endothelial cells imply that CCM3 acts via the STRIPAK
a
c
b
d
Fig. 6 Effect of FAM40A and FAM40B depletion on endothelial junctions and permeability. a HUVECs were transfected with siRNAs targeting FAM40A or
FAM40B and seeded onto fibronectin-coated glass coverslips to form monolayers. 72 h after transfection cells were fixed and stained for F-actin and VE-
cadherin. b Immunofluorescence analysis of FAM40A and FAM40B-depleted HUVECs for F-actin and ZO-1. Images are compressed stacks of 10–15 z-
sections and are representative of 3 independent experiments. Scale bars, 40 μm. c Magnified images highlighting anchoring of stress fibers at cell-cell
junctions. d HUVECs were transfected with the indicated siRNAs and plated at confluency onto transwell inserts. 72 h after transfection, FITC-dextran was
added to the upper chamber. After a further 80 min the fluorescence of media in the lower chamber was determined. Data show mean permeability ±
SEM as % of siControl; n= 3 independent experiments for siFAM40A; n= 5 independent experiments for siFAM40B. *p< 0.05, **p< 0.01; Student’s t-test,
compared to siControl
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ac
b
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Fig. 7 FAM40A and FAM40B regulate endothelial loop formation. a HUVECs were transfected with siRNAs targeting FAM40A and FAM40B. 48 h
after transfection cells were seeded onto a layer of Matrigel. Loops were allowed to form for 24 h. Scale bar, 200 μm. Graph (right panel) shows
quantification of number of loops per field. At least 5 fields were scored per condition in each experiment. Data show mean ± SEM normalised to
siControl; n = 4 for siFAM40A-1, siFAM40A-2 and siFAM40B-1; n = 3 for siFAM40B-2. b Arrows highlight deformation of the Matrigel substrate by
FAM40-depleted cells. Scale bars, 200 μm. c HUVECs were allowed to form loops on polymerised Matrigel for 24 h, and were fixed and stained for
F-actin, and with DAPI to visualise nuclei. Images are sections taken at a single z-position and are representative of 3 independent experiments. Boxed
areas are shown at higher magnification (inset images) to highlight F-actin micro-spikes on cells. Scale bar, 40 μm. d FAM40A and FAM40B-depleted
HUVECs were allowed to form loops on polymerised Martigel for 24 h. Cells were treated with 10 μM Y-27632 for 24 h. Scale bar, 200 μm. Graph (right
panel) shows quantification of number of loops per field. At least 4 fields were scored per condition in each experiment. Data are mean ± SEM
normalised to siControl, n = 3 independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001; Student’s t-test, compared to siControl
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complex to regulate endothelial function, and thus that
altering the activity of specific STRIPAK components
could alleviate the symptoms in patients with cerebral
cavernous malformation.
Methods
Antibodies
The following antibodies were used for western blotting: rat
anti-HA (3F10; Roche/Sigma-Aldrich), rabbit anti-myc,
mouse anti-RhoA, rabbit anti-MLC2 (Santa Cruz Technol-
ogy), rabbit anti-FAM40B (Sigma-Aldrich), rabbit anti-
pThr18/pSer19-MLC2 (Cell Signaling), mouse anti-
GADPH (Millipore), secondary HRP-conjugated sheep
anti-mouse IgG and donkey anti-rabbit IgG (GE Health-
care). Antibodies for immunofluorescence analysis were:
rabbit anti-HA (Santa Cruz Technology), rabbit anti-
pSer19-MLC2 (Cell Signaling), mouse anti-VE-cadherin
(BD Biosciences), rabbit anti-ZO-1 (#61–7300; Thermo-
Fisher Scientific), secondary AlexaFluor-488 and -647-con-
jugated antibodies (Molecular Probes). Cells were also
stained with DAPI (DNA) and AlexaFluor-546-labeled
phalloidin (F-actin; Molecular Probes).
Cell culture and siRNA transfection
Pooled human umbilical vein endothelial cells
(HUVECs) obtained from Lonza or PromoCell were cul-
tured in EBM-2 medium containing the appropriate
growth factors (EGM-2) and supplemented with 2%
foetal bovine serum (FBS). Cell culture dishes were
coated with 10 μg/ml fibronectin for 1 h at 37 °C prior
to cell seeding. HUVECs were used until passage 4.
Where indicated, they were stimulated with 1 U/ml
thrombin (Sigma-Aldrich) for 10 min.
COS7 cells were cultured in DMEM containing 10%
FBS, penicillin (100 IU/ml) and streptomycin (100 μg/ml).
HUVECs were transfected with 50 nM siRNAs using
Oligofectamine in EGM-2 medium containing 4% FCS.
After 16 h, medium was changed to EGM-2 containing
2% FCS. Cells were analysed 72 h after siRNA transfec-
tion. The following siRNA sequences were obtained
from Dharmacon (GE Healthcare): siFAM40A-1 (5’-GC
UGAUGACUCUCGAGAAG-3′), siFAM40A-2 (5’-CAG
CACAAGUACACGUCGA-3′), siFAM40B-1 (5’-GAAG
GCAACUCCUCACUAA-3′), siFAM40B-2 (5’-UGAC
UGGGCUUACGGGAAU-3′), siControl (5’-UGGU
UUACAUGUCGACUAA-3′). CCM3 siRNAs were
obtained from Ambion (ThermoFisher Scientific):
siCCM3–1 (5’-GUGAUACUCUGAAAACGUA-3′),
siCCM3–2 (5’-AGAAAAUCCAGGUCUCACA-3′).
cDNA cloning and plasmid transfection
Human FAM40A, FAM40B and CCM3 cDNAs were
kindly provided in pENTRY by Dr. Stefan Wiemann
(DKFZ, Germany). The FAM40A and FAM40B cDNAs
were cloned into pDEST-HA, and CCM3 into pDEST-
myc, using a Gateway™ LR Clonase II Enzyme kit (Invi-
trogen) as recommended by the manufacturer.
HUVECs were transfected with plasmid DNA with an
Amaxa Nucleofector (Lonza) according to the manufac-
turer’s instructions. After nucleofection, cells were plated
onto fibronectin-coated glass coverslips for immuno-
fluorescence analysis.
COS7 cells were transfected with plasmid DNA using
a Genepulser II System (Bio-Rad) at 250 V, 975 μF in
electroporation buffer (120 mM KCl, 10 mM K2PO4/
KHPO4 pH 7.6, 25 mM HEPES pH 7.6, 2 mM MgCl2,
0.5% Ficoll 400). After 48 h, cells were lysed for immu-
noprecipitation analysis.
Immunoprecipitation and immunoblotting
Cells were lysed in either IP lysis buffer (20 mM Tris-Cl
pH 8, 130 mM NaCl, 1% Triton X-100, 1 mM DTT,
10 mM NaF, EDTA-free protease inhibitor cocktail (Roche
Applied Science), phosphatase inhibitor cocktail (Calbio-
chem)) or RIPA buffer (20 mM Tris-Cl pH 7.5, 150 mM
NaCl, 1 mM EDTA, 1% NP-40, 0.5% sodium deoxycho-
late, 0.1% SDS, 1 mM DTT, 125 mM NaF, EDTA-free pro-
tease inhibitor cocktail, phosphatase inhibitor cocktail).
For immunoprecipitations, COS7 cell lysates were
pre-cleared by incubation with non-immune IgG agarose
beads (Sigma-Aldrich) for 1 h at 4 °C, then incubated with
mouse anti-HA agarose beads (Sigma-Aldrich) for 3 h at
4 °C. Beads were washed with high salt IP lysis buffer
(containing 250 mM NaCl). Proteins were eluted from the
beads with sample buffer (4% SDS, 160 mM Tris-Cl
pH 6.8, 20% glycerol, 10 mM DTT). Empty vector was
transfected as a control to demonstrate that the anti-HA
beads did not pull down myc-CCM3 directly.
For pMLC2 analysis, HUVECs were lysed with Laemmli
lysis buffer (80 mM Tris-Cl pH 7.5, 10% glycerol, 2% SDS,
10 mM glycerol phosphate, 1 mM Na3VO4, 1 mM DTT,
10 mM NaF, 1 mM PMSF, EDTA-free protease inhibitor
cocktail). Cell lysates were snap frozen in liquid nitrogen,
then boiled for 5 min and sonicated before centrifugation.
Cell lysates were separate by SDS-PAGE using pre-cast
4–12% Bis-Tris gels (Life Technologies). Proteins were
transferred onto PVDF membranes (Immobilon-P; Milli-
pore). Membranes were blocked in 5% skimmed milk
powder 5% BSA, incubated with primary antibodies in
blocking solution, followed by HRP-conjugated secondary
antibodies and detection by enhanced chemiluminescence
(ECL) (GE Healthcare) according to the manufacturer’s
instructions. Bands on immunoblots were quantified by
densitometric analysis using ImageJ software.
RhoA activity assay
GST-Rhotekin-RBD was purified from E. coli on gluta-
thione sepharose beads (GE Healthcare) as previously
Suryavanshi et al. BMC Cell Biology           (2018) 19:26 Page 11 of 13
described [27]. HUVECs were lysed with Rho lysis buffer
(50 mM Tris-Cl pH 7.5, 500 mM NaCl, 10 mM MgCl2,
10% glycerol, 0.1% SDS, 1% Triton X-100, 0.5% sodium
deoxycholate, 25 mM NaF, 1 mM Na3VO4, 1 mM PMSF,
EDTA-free protease inhibitor cocktail). A small aliquot
of the lysate was kept to determine total RhoA levels.
Lysates were then incubated with GST-RBD for 1 h at
4 °C with rotation. Protein was eluted from the beads by
boiling with 4× Laemmli sample buffer and analysed by
western blotting.
Immunofluorescence and confocal microscopy
HUVECs were seeded onto glass coverslips coated with
fibronectin (10 μg/ml at 37 °C for overnight). Cells were
fixed in 4% paraformaldehyde, permeabilized with 0.1%
Triton X-100 and blocked in 3% BSA. Primary anti-
bodies were diluted in 1% BSA in PBS. Fluorophore-
conjugated secondary antibodies, DAPI and phalloidin
were prepared in the same way as the primary anti-
bodies. Coverslips were mounted onto glass slides using
fluorescent mounting medium (DAKO).
A Zeiss LSM510 confocal laser-scanning microscope
with an EC Plan-Neofluar 40×/1.30 Oil DIC M27 or a
Plan-Apochromat 63×/1.40 Oil DIC M27, and ZEN soft-
ware was used to take images of fluorescently stained
cells. Images in each experiment were acquired using
the same gain and offset settings.
Stress fibers were quantified by assigning a score to each
cell based on the stress fiber content in the centre of the
cell; 0 – few or no stress fibers, 1 – up to 50% of the cell
centre contains stress fibers, 2–50% to 75% of the cell
centre contains stress fibers, 3 – greater than 75% of the
cell centre contains stress fibers. The experimenter quan-
tifying stress fibers was blinded to the treatment.
Endothelial permeability assay
HUVECs were transfected with siRNAs and after 48 h were
plated onto fibronectin-coated (10 μg/ml at 37 °C for 1 h)
Transwell filters (12-mm diameter, 0.4-μm pore size, Co-
star) to form confluent monolayers. After 24 h, 0.1 mg/ml
FITC dextran (molecular weight 42 kDa) was added to the
upper chamber. Fluorescence was measured in the lower
chamber after 80 min using a microplate analyser
(Fusion-FA; PerkinElmer; excitation, 485 nm; detection,
523–535 nm). Each condition was performed in triplicate.
Angiogenic loop formation assay
Matrigel (BD Biosciences, at least 9 mg/ml) was diluted
1:1 with PBS, 300 μl added to each well of a 6-well dish
and allowed to polymerize for 1.5 h. HUVECs were
transfected with siRNAs and after 48 h 2 × 105 cells per
well were seeded onto Matrigel, with or without addition
of 10 μM ROCK inhibitor Y-27632 (Calbiochem). Cells
were imaged after 24 h by phase-contrast microscopy
using a Nikon TE2000-E microscope with a Plan Fluor
4× or 10× objective (Nikon) and a Hamamatsu Orca-ER
digital camera, or fixed, permeabilized and stained for
F-actin as described above (Immunofluorescence and
confocal microscopy). The number of loops formed per
imaged field was counted. The mean value of loops for
multiple fields was used for statistical analysis. Alterna-
tively, phase-contrast time-lapse movies were acquired
1 h after seeding cells onto Matrigel at 37 °C and 5%
CO2. Images were captured using Metamorph software
at a frame rate of 1 frame/30 min for 24 h.
qPCR
Total RNA was extracted 72 h after siRNA transfection
using either an RNeasy mini kit (Qiagen) according to
the manufacturer’s instructions or with Trizol and
chloroform extraction. Purified RNA was treated with
DNase (DNA free kit, Ambion). A SuperScript® VILO™
cDNA synthesis kit (Invitrogen) was used to synthesise
cDNA according to the manufacturer’s instructions.
qPCR was carried out with SYBR green detection
chemistry (mastermix from Primer Design). GAPDH
was used as a reference gene. Data were acquired using
either an ABI Prism 7000 system (Applied Biosystems)
or the MX3005p system (Agilent Technologies) and ana-
lysed with ABI7000 SDS analysis software or with
MxPro QPCR software respectively. Cycle to threshold
(CT) values were determined for each condition, normal-
ised to GAPDH levels and % mRNA expression normal-
ised to control siRNA calculated as (100/(2 ^ (CT shift)).
Additional files
Additional file 1: Figure S1. Thrombin induces an increase in MLC2
phosphorylation. (A) HUVECs were treated with 1 U/ml thrombin for
10 min, then lysed and analysed by immunoblotting for phospho-MLC2
(pMLC2) and MLC2. GAPDH was used as a loading control. Results for 3
separate experiments (Exp.) are shown. (B) Quantification of pMLC2 levels
was performed by individually normalising pMLC2 and MLC2 levels to
GAPDH levels. The ratio of the normalised pMLC2 level to the normalised
MLC2 level was used as a measure of MLC2 phosphorylation, and is
shown for thrombin stimulation as % of control cells (no thrombin). Data
are means of 3 independent experiments ± SEM (PDF 166 kb).
Additional file 2: siControl. (AVI 1920 kb)
Additional file 3: siControl+Y. (AVI 1820 kb)
Additional file 4: siFAM40A. (AVI 2030 kb)
Additional file 5: siFAM40A+Y. (AVI 2490 kb)
Additional file 6: siFAM40B. (AVI 1680 kb)
Additional file 7: siFAM40B+Y. (AVI 1860 kb)
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